Literature DB >> 30928476

Orthostatic vital signs do not predict 30 day serious outcomes in older emergency department patients with syncope: A multicenter observational study.

Jennifer L White1, Judd E Hollander2, Anna Marie Chang2, Daniel K Nishijima3, Amber L Lin3, Erica Su4, Robert E Weiss4, Annick N Yagapen3, Susan E Malveau3, David H Adler5, Aveh Bastani6, Christopher W Baugh7, Jeffrey M Caterino8, Carol L Clark9, Deborah B Diercks10, Bret A Nicks11, Manish N Shah12, Kirk A Stiffler13, Alan B Storrow14, Scott T Wilber13, Benjamin C Sun3.   

Abstract

BACKGROUND: Syncope is a common chief complaint among older adults in the Emergency Department (ED), and orthostatic vital signs are often a part of their evaluation. We assessed whether abnormal orthostatic vital signs in the ED are associated with composite 30-day serious outcomes in older adults presenting with syncope.
METHODS: We performed a secondary analysis of a prospective, observational study at 11 EDs in adults ≥ 60 years who presented with syncope or near syncope. We excluded patients lost to follow up. We used the standard definition of abnormal orthostatic vital signs or subjective symptoms of lightheadedness upon standing to define orthostasis. We determined the rate of composite 30-day serious outcomes, including those during the index ED visit, such as cardiac arrhythmias, myocardial infarction, cardiac intervention, new diagnosis of structural heart disease, stroke, pulmonary embolism, aortic dissection, subarachnoid hemorrhage, cardiopulmonary resuscitation, hemorrhage/anemia requiring transfusion, with major traumatic injury from fall, recurrent syncope, and death) between the groups with normal and abnormal orthostatic vital signs.
RESULTS: The study cohort included 1974 patients, of whom 51.2% were male and 725 patients (37.7%) had abnormal orthostatic vital signs. Comparing those with abnormal to those with normal orthostatic vital signs, we did not find a difference in composite 30-serious outcomes (111/725 (15.3%) vs 184/1249 (14.7%); unadjusted odds ratio, 1.05 [95%CI, 0.81-1.35], p = 0.73). After adjustment for gender, coronary artery disease, congestive heart failure (CHF), history of arrhythmia, dyspnea, hypotension, any abnormal ECG, physician risk assessment, medication classes and disposition, there was no association with composite 30-serious outcomes (adjusted odds ratio, 0.82 [95%CI, 0.62-1.09], p = 0.18).
CONCLUSIONS: In a cohort of older adult patients presenting with syncope who were able to have orthostatic vital signs evaluated, abnormal orthostatic vital signs did not independently predict composite 30-day serious outcomes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30928476      PMCID: PMC6761041          DOI: 10.1016/j.ajem.2019.03.036

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  22 in total

1.  Effect of sleep restriction on orthostatic cardiovascular control in humans.

Authors:  N K Muenter; D E Watenpaugh; W L Wasmund; S L Wasmund; S A Maxwell; M L Smith
Journal:  J Appl Physiol (1985)       Date:  2000-03

2.  Segmental orthostatic fluid shifts.

Authors:  A Diedrich; I Biaggioni
Journal:  Clin Auton Res       Date:  2004-06       Impact factor: 4.435

3.  2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Win-Kuang Shen; Robert S Sheldon; David G Benditt; Mitchell I Cohen; Daniel E Forman; Zachary D Goldberger; Blair P Grubb; Mohamed H Hamdan; Andrew D Krahn; Mark S Link; Brian Olshansky; Satish R Raj; Roopinder Kaur Sandhu; Dan Sorajja; Benjamin C Sun; Clyde W Yancy
Journal:  Heart Rhythm       Date:  2017-03-09       Impact factor: 6.343

4.  Prevalence of postural hypotension in elderly patients in a long-term health care facility.

Authors:  W S Aronow; N H Lee; F F Sales; F Etienne
Journal:  Am J Cardiol       Date:  1988-08-01       Impact factor: 2.778

5.  The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting.

Authors:  Jin H Han; Christopher J Lindsell; Alan B Storrow; Samuel Luber; James W Hoekstra; Judd E Hollander; W Franklin Peacock; Charles V Pollack; W Brian Gibler
Journal:  Ann Emerg Med       Date:  2006-12-04       Impact factor: 5.721

6.  National trends in resource utilization associated with ED visits for syncope.

Authors:  Marc A Probst; Hemal K Kanzaria; Misato Gbedemah; Lynne D Richardson; Benjamin C Sun
Journal:  Am J Emerg Med       Date:  2015-04-24       Impact factor: 2.469

7.  Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness.

Authors:  Chiara Mussi; Andrea Ungar; Gianfranco Salvioli; Carlo Menozzi; Angelo Bartoletti; Franco Giada; Alfonso Lagi; Irene Ponassi; Giuseppe Re; Raffaello Furlan; Roberto Maggi; Michele Brignole
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-04-06       Impact factor: 6.053

8.  Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope.

Authors:  Venkatesh Thiruganasambandamoorthy; Kenneth Kwong; George A Wells; Marco L A Sivilotti; Muhammad Mukarram; Brian H Rowe; Eddy Lang; Jeffrey J Perry; Robert Sheldon; Ian G Stiell; Monica Taljaard
Journal:  CMAJ       Date:  2016-07-04       Impact factor: 8.262

Review 9.  Orthostatic hypotension for the cardiologist.

Authors:  Philip L Mar; Satish R Raj
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

Review 10.  The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Authors:  Christopher H Gibbons; Peter Schmidt; Italo Biaggioni; Camille Frazier-Mills; Roy Freeman; Stuart Isaacson; Beverly Karabin; Louis Kuritzky; Mark Lew; Phillip Low; Ali Mehdirad; Satish R Raj; Steven Vernino; Horacio Kaufmann
Journal:  J Neurol       Date:  2017-01-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.